期刊
ENEURO
卷 5, 期 2, 页码 -出版社
SOC NEUROSCIENCE
DOI: 10.1523/ENEURO.0395-17.2018
关键词
Microglia; middle cerebral artery occlusion; naloxone; NF-kappa B; secondary injury; stroke
资金
- Academy of Finland [250275, 256398, 281394, 309489]
- Biocentrum Helsinki
- Sigrid Juselius Foundation
- EU FP7 GLORIA [602919]
- 3iRegeneration - Tekes
- National Institute on Drug Abuse, Intramural Research Program at the National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism
- Ella and Georg Ehrnrooth Foundation
- Paivikki and Sakari Sohlberg Foundation
- Alfred Kordelin Foundation
- Orion Research Foundation
- Academy of Finland (AKA) [309489, 309489] Funding Source: Academy of Finland (AKA)
Ischemic stroke is the leading cause of disability, and effective therapeutic strategies are needed to promote complete recovery. Neuroinflammation plays a significant role in stroke pathophysiology, and there is limited understanding of how it affects recovery. The aim of this study was to characterize the spatiotemporal expression profile of microglial activation and whether dampening microglial/macrophage activation post-stroke facilitates the recovery. For dampening microglial/macrophage activation, we chose intranasal administration of naloxone, a drug that is already in clinical use for opioid overdose and is known to decrease microglia/macrophage activation. We characterized the temporal progression of microglia/macrophage activation following cortical ischemic injury in rat and found the peak activation in cortex 7 d post-stroke. Unexpectedly, there was a chronic expression of phagocytic cells in the thalamus associated with neuronal loss. (+)-Naloxone, an enantiomer that reduces microglial activation without antagonizing opioid receptors, was administered intranasally starting 1 d post-stroke and continuing for 7 d. (+)-Naloxone treatment decreased microglia/macrophage activation in the striatum and thalamus, promoted behavioral recovery during the 14-d monitoring period, and reduced neuronal death in the lesioned cortex and ipsilateral thalamus. Our results are the first to show that post-stroke intranasal (+)-naloxone administration promotes short-term functional recovery and reduces microglia/macrophage activation. Therefore, (+)-naloxone is a promising drug for the treatment of ischemic stroke, and further studies should be conducted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据